Seres Therapeutics, Inc. (MCRB) Insider Trading

Name: Seres Therapeutics, Inc. (MCRB) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 18, 2026): Kelly Brady (EVP, Chief Operating Officer): Exercise/Conversion of 181 shares.

Get alerted when insiders trade MCRB

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta